Form 4: Phibro CEO Jack Bendheim Converts, Sells Shares

Phibro Animal Health Corp's President and CEO, Jack Bendheim, converted Class B shares to Class A and subsequently sold a portion of Class A shares through a pre-arranged trading plan.

Summary

• Jack Bendheim, President and CEO, Director, and 10% Owner of Phibro Animal Health Corp (PAHC), along with BFI Co., LLC (a 10% owner over which Mr. Bendheim exercises control), reported changes in beneficial ownership.
• On December 3, 2025, 30,000 shares of Class B Common Stock were converted into 30,000 shares of Class A Common Stock on a one-for-one basis.
• Following the conversion, BFI Co., LLC indirectly held 56,800 shares of Class A Common Stock.
• On December 3, 2025, BFI Co., LLC sold 3,520 shares of Class A Common Stock at a weighted average price of $40.7701 per share.
• On December 4, 2025, BFI Co., LLC sold an additional 3,152 shares of Class A Common Stock at a weighted average price of $41.1584 per share.
• Also on December 4, 2025, BFI Co., LLC sold 368 shares of Class A Common Stock at a weighted average price of $41.7517 per share.
• All reported sales by BFI Co., LLC were executed pursuant to a Rule 10b5-1 trading plan adopted on May 30, 2025.
• After these transactions, BFI Co., LLC indirectly beneficially owns 49,760 shares of Class A Common Stock, and Jack Bendheim directly holds 16,840 shares of Class A Common Stock.
• Mr. Bendheim disclaims beneficial ownership of the securities held by BFI Co., LLC except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider sales can sometimes be viewed negatively, these transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests they are not based on new, material non-public information and are part of a systematic approach to managing personal holdings.

Positives

• The conversion of Class B Common Stock to Class A Common Stock provides increased liquidity for the holder, as Class A shares are typically more readily tradable.

Negatives

• The sale of 7,040 shares of Class A Common Stock by BFI Co., LLC, an entity controlled by the CEO, represents a reduction in insider ownership, which can sometimes be perceived negatively by investors.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction report is specific to Phibro Animal Health Corp and does not provide broader industry context or trends. Insider trading activity is a common occurrence across all industries, with Rule 10b5-1 plans often used to manage executive stock holdings systematically.

Stakeholder Impact

• Shareholders: May observe a slight reduction in direct insider ownership, though the pre-planned nature of the sales mitigates concerns about management's confidence in the company's future.

Key Dates

Recommendation

The reported transactions are insider sales executed under a Rule 10b5-1 trading plan. Such plans are pre-arranged and typically not indicative of a change in management's fundamental view of the company's prospects. While a reduction in insider ownership is noted, it does not provide a strong signal for either buying or selling the stock, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

PAHC, Phibro Animal Health, Jack Bendheim, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership